A Study of Oral Hymecromone to Treat Adults With Primary Sclerosing Cholangitis

Clinical Trial ID NCT02780752

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02780752

Top papers

Rank Title Journal Year PubWeight™‹?›
1 4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer. Front Immunol 2015 0.95
2 Inhibition of hyaluronan synthesis restores immune tolerance during autoimmune insulitis. J Clin Invest 2015 0.82
Next 100